KEGG enrichment analysis indicated that GLUT3 was involved in modulating various pathways in cells, including hyperglycemia-, tumor angiogenesis-, and cancer-related signaling pathways (Fig. 4d). The gene discussed is SLC2A3; the disease is cancer.